Zenas BioPharma, Inc. Common Stock (ZBIO) News
Latest headlines that mention ZBIO, newest first · each headline opens the original publisher
- Last price
- $27.24
- Day change
- +1.38%
- Next earnings
- —
ZBIO headlines
latest coverageThis clinical-stage biotech focused on immunology therapies reported a notable insider buy amid a year of strong stock performance.
ZBIO news alerts
Get an alert by email or push when a new headline mentions ZBIO.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.